Li, Z, Mirams, G, Yoshinaga, T, Ridder, B, Han, X, Chen, JE, Stockbridge, NL, Wisialowski, TA, Damiano, B, Severi, S, Morissette, P, Kowey, PR, Holbrook, M, Smith, G, Rasmusson, RL, Liu, M, Song, Z, Qu, Z, Leishman, DJ, Steidl‐Nichols, J, Rodriguez, B, Bueno-Orovio, A, Zhou, X, Passini, E, Edwards, AG, Morotti, S, Ni, H, Grandi, E, Clancy, CE, Vandenberg, J, Hill, A, Nakamura, M, Singer, T, Polonchuk, L, Paci, M, Greiter‐Wilke, A, Wang, K, Nave, S, Fullerton, A, Sobie, EA, Tshinanu, FM & Strauss, DG 2019, '
General principles for the validation of proarrhythmia risk prediction models: an extension of the CiPA In Silico strategy',
CLINICAL PHARMACOLOGY AND THERAPEUTICS.
https://doi.org/10.1002/cpt.1647